Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Clinical trial NCT03338621 · COMPLETED

Trial details

NCT number: NCT03338621
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary Tuberculosis, Multidrug-Resistant Tuberculosis, MDR Tuberculosis Drug-Resistant Tuberculosis

Start date: 2018-07-30
Primary completion: 2021-07-01
Enrollment: 455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.